References
- Steinbach WJ, Perfect JR. Scedosporium species infections and treatments. J Chemother 2003; 15(Suppl 2)16–27
- Idigoras P, Perez-Trallero E, Pineiro L, Larruskain J, Lopez-Lopategui MC, Rodriguez N, et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990–1999. Clin Infect Dis 2001; 32: e158–65
- Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 2002; 34: 1648–50
- Nesky MA, McDougal EC, Peacock JE, Jr. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 2000; 31: 673–7
- Jabado N, Casanova JL, Haddad E, Dulieu F, Fournet JC, Dupont B, et al. Invasive pulmonary infection due to Scedosporium apiospermum in 2 children with chronic granulomatous disease. Clin Infect Dis 1998; 27: 1437–41
- Gompels MM, Bethune CA, Jackson G, Spickett GP. Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant. J Clin Pathol 2002; 55: 784–6
- Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002; 21: 240–8
- Wood GM, McCormack JG, Muir DB, Ellis DH, Ridley MF, Pritchard R, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027–33
- Berenguer J, Rodriguez-Tudela JL, Richard C, Alvarez M, Sanz MA, Gaztelurrutia L, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76: 256–65
- Maertens J, Lagrou K, Deweerdt H, Surmont I, Verhoef GE, Verhaegen J, et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among hematology patients. Case report and review. Ann Hematol 2000; 79: 340–4
- Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003; 15: 578–84
- Meletiadis J, Mouton JW, Meis JFGM, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47: 106–17
- Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003; 22: 111–3
- Gosbell IB, Toumasatos V, Yong J, Kuo RS, Ellis DH, Perrie RC. Cure of orthopedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 2003; 46: 233–6
- Whyte M, Irving H, O'Regan P, Nissen M, Siebert D, Labrom R. Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia. Pediatr Infect Dis J 2005; 24: 375–7
- Singh RP, McCluskey P. Scedosporium prolificans sclerokeratitis 10 y after pterygium excision with adjunctive mitomycin C. Clin Experiment Ophthalmol 2005; 33: 433–4